Dr Francis Mussai
Clinical Senior Lecturer in Paediatric Oncology/Honorary Consultant
Dr Mussai trained at Oxford University and has worked at some of the top cancer facilities in the world including Johns Hopkins Hospital in Baltimore, USA and the National Cancer Institute in Washington DC, USA.
Dr Mussai looks after children diagnosed with solid cancers and can be seen on the ward and in the outpatient clinic. He leads the International Fellowship Programme in the department which has now trained doctors from around the world. He is involved in early phase clinical trials of novel therapeutic drugs and sits on the Innovative Therapies for Children with Cancer (ITCC) Clinical Trials Committee, as well as a number of national committees involved in identifying new drugs for children with cancer.
Dr Mussai investigates how solid cancers and leukaemias interact with the immune system and has a research laboratory at the University of Birmingham. By improving our understanding of how cancers escape from immune attack he believes new therapies can be developed to improve the outcome for our patients. He has published a number of papers in this field. The laboratory’s research has led to a number of international clinical trials of new drugs and immunotherapies.
To find out more about Dr Mussai’s research see his University of Birmingham profile.
0121 333 8234
- Reseach into how cancers escape the immune system
- Novel therapeutic drugs for leukaemias
- Dr Mussai is a Fellow of the Royal College of Physicians